Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amanda L Gross

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Protein Engineering, Design & Selection : PEDS|January 15, 2016
Promiscuous tumor targeting phage proteinsAmanda L Gross, James W Gillespie, Valery A Petrenko
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 7, 2007
Modulation of CA3 afferent inputs by novelty and theta rhythmDesiree M Villarreal, Amanda L Gross, Brian E Derrick
Nanomedicine (London, England)|November 8, 2017
Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapyJessica M Kelly, Amanda L Gross, Douglas R Martin, et al.
Frontiers in Microbiology|July 10, 2015
Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteinsJames W Gillespie, Amanda L Gross, Anatoliy T Puzyrev, et al.
Microbiology Spectrum|April 25, 2022
Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese CatsXiaolei Ma, Emily Brinker, Emily C Graff, et al.
The International Journal of Neuropsychopharmacology|February 4, 2017
IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural PlasticityJeffrey Burgdorf, Elizabeth M Colechio, Nayereh Ghoreishi-Haack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effectsJeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, et al.
Behavioural Brain Research|July 27, 2015
Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of ratsJeffrey Burgdorf, Roger A Kroes, Xiao-lei Zhang, et al.
The International Journal of Neuropsychopharmacology|November 4, 2017
NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and MemoryM Amin Khan, David R Houck, Amanda L Gross, et al.
Journal of the American Veterinary Medical Association|December 8, 2022
Rabies: who should care?Henry J Baker, Douglas R Martin, Amanda L Gross, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Protein Engineering, Design & Selection : PEDS|January 15, 2016
Promiscuous tumor targeting phage proteinsAmanda L Gross, James W Gillespie, Valery A Petrenko
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 7, 2007
Modulation of CA3 afferent inputs by novelty and theta rhythmDesiree M Villarreal, Amanda L Gross, Brian E Derrick
Nanomedicine (London, England)|November 8, 2017
Polyethylene glycol-b-poly(lactic acid) polymersomes as vehicles for enzyme replacement therapyJessica M Kelly, Amanda L Gross, Douglas R Martin, et al.
Frontiers in Microbiology|July 10, 2015
Combinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteinsJames W Gillespie, Amanda L Gross, Anatoliy T Puzyrev, et al.
Microbiology Spectrum|April 25, 2022
Whole-Genome Shotgun Metagenomic Sequencing Reveals Distinct Gut Microbiome Signatures of Obese CatsXiaolei Ma, Emily Brinker, Emily C Graff, et al.
The International Journal of Neuropsychopharmacology|February 4, 2017
IGFBP2 Produces Rapid-Acting and Long-Lasting Effects in Rat Models of Posttraumatic Stress Disorder via a Novel Mechanism Associated with Structural PlasticityJeffrey Burgdorf, Elizabeth M Colechio, Nayereh Ghoreishi-Haack, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 11, 2013
GLYX-13, a NMDA receptor glycine-site functional partial agonist, induces antidepressant-like effects without ketamine-like side effectsJeffrey Burgdorf, Xiao-lei Zhang, Katherine L Nicholson, et al.
Behavioural Brain Research|July 27, 2015
Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of ratsJeffrey Burgdorf, Roger A Kroes, Xiao-lei Zhang, et al.
The International Journal of Neuropsychopharmacology|November 4, 2017
NYX-2925 Is a Novel NMDA Receptor-Specific Spirocyclic-β-Lactam That Modulates Synaptic Plasticity Processes Associated with Learning and MemoryM Amin Khan, David R Houck, Amanda L Gross, et al.
Journal of the American Veterinary Medical Association|December 8, 2022
Rabies: who should care?Henry J Baker, Douglas R Martin, Amanda L Gross, et al.
Pageof 3